57 related articles for article (PubMed ID: 28588720)
1. Histone deacetylase inhibitor trichostatin A sensitises cisplatin-resistant ovarian cancer cells to oncolytic adenovirus.
Hulin-Curtis SL; Davies JA; Jones R; Hudson E; Hanna L; Chester JD; Parker AL
Oncotarget; 2018 May; 9(41):26328-26341. PubMed ID: 29899862
[TBL] [Abstract][Full Text] [Related]
2. Anthelmintic drug albendazole arrests human gastric cancer cells at the mitotic phase and induces apoptosis.
Zhang X; Zhao J; Gao X; Pei D; Gao C
Exp Ther Med; 2017 Feb; 13(2):595-603. PubMed ID: 28352336
[TBL] [Abstract][Full Text] [Related]
3. Effect of substituents at the C3´, C3´N, C10 and C2-meta-benzoate positions of taxane derivatives on their activity against resistant cancer cells.
Daniel P; Balušíková K; Truksa J; Černý J; Jaček M; Jelínek M; Mulenga MJV; Voráčová K; Chen L; Wei L; Sun Y; Ojima I; Kovář J
Toxicol Appl Pharmacol; 2024 Jun; 489():116993. PubMed ID: 38870637
[TBL] [Abstract][Full Text] [Related]
4. The LIV-1-GRPEL1 axis adjusts cell fate during anti-mitotic agent-damaged mitosis.
Chen P; Wang B; Mo Q; Wu P; Fang Y; Tian Y; Jin X; Gao Y; Wu Y; Cao Y; Zhang Y; Xi L; Wang S; Hu J; Ma D; Zhou J; Gao Q; Chen G
EBioMedicine; 2019 Nov; 49():26-39. PubMed ID: 31636012
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review.
Bouyahya A; El Omari N; Bakha M; Aanniz T; El Menyiy N; El Hachlafi N; El Baaboua A; El-Shazly M; Alshahrani MM; Al Awadh AA; Lee LH; Benali T; Mubarak MS
Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297347
[TBL] [Abstract][Full Text] [Related]
6. Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease.
Kulka LAM; Fangmann PV; Panfilova D; Olzscha H
Front Cell Dev Biol; 2020; 8():425. PubMed ID: 32582706
[TBL] [Abstract][Full Text] [Related]
7. A novel computational approach for drug repurposing using systems biology.
Peyvandipour A; Saberian N; Shafi A; Donato M; Draghici S
Bioinformatics; 2018 Aug; 34(16):2817-2825. PubMed ID: 29534151
[TBL] [Abstract][Full Text] [Related]
8. Novel biomolecule lycopene-reduced graphene oxide-silver nanoparticle enhances apoptotic potential of trichostatin A in human ovarian cancer cells (SKOV3).
Zhang XF; Huang FH; Zhang GL; Bai DP; Massimo DF; Huang YF; Gurunathan S
Int J Nanomedicine; 2017; 12():7551-7575. PubMed ID: 29075115
[TBL] [Abstract][Full Text] [Related]
9. β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cells.
Zou B; Li QQ; Zhao J; Li JM; Cuff CF; Reed E
Anticancer Res; 2013 Mar; 33(3):929-40. PubMed ID: 23482764
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Taxane Resistance.
Maloney SM; Hoover CA; Morejon-Lasso LV; Prosperi JR
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182737
[TBL] [Abstract][Full Text] [Related]
11. Synergistic activity of the histone deacetylase inhibitor trichostatin A and the proteasome inhibitor PS-341 against taxane-resistant ovarian cancer cell lines.
Jin X; Fang Y; Hu Y; Chen J; Liu W; Chen G; Gong M; Wu P; Zhu T; Wang S; Zhou J; Wang H; Ma D; Li K
Oncol Lett; 2017 Jun; 13(6):4619-4626. PubMed ID: 28588720
[TBL] [Abstract][Full Text] [Related]
12. Synergistic efficacy in human ovarian cancer cells by histone deacetylase inhibitor TSA and proteasome inhibitor PS-341.
Fang Y; Hu Y; Wu P; Wang B; Tian Y; Xia X; Zhang Q; Chen T; Jiang X; Ma Q; Xu G; Wang S; Zhou J; Ma D; Meng L
Cancer Invest; 2011 May; 29(4):247-52. PubMed ID: 21345073
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2-related protein Bad.
Strait KA; Warnick CT; Ford CD; Dabbas B; Hammond EH; Ilstrup SJ
Mol Cancer Ther; 2005 Apr; 4(4):603-11. PubMed ID: 15827334
[TBL] [Abstract][Full Text] [Related]
14. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
